Other
2029
Amgen 2029 decreased by 17.9% to $2.3B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 17.9%, from $2.8B to $2.3B.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ1 2016
Last reportedQ1 2026Apr 30, 2026
Metric ID:
other_finite_lived_intangible_assets_amortization_expens_a9462eHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.4B | $2.4B | $2.4B | $2.4B | $2.2B | $2.2B | $2.1B | $2.1B | $3.9B | $3.9B | $3.9B | $2.8B | $2.9B | $2.8B | $2.3B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -8.3% | +0.0% | -4.5% | +0.0% | +85.7% | +0.0% | +0.0% | -28.2% | +3.6% | -3.4% | -17.9% |
| YoY Change | — | — | — | +0.0% | -8.3% | -8.3% | -12.5% | -4.5% | +77.3% | +85.7% | +85.7% | -28.2% | -25.6% | -28.2% | -17.9% |
Range$2.1B – $3.9B
CAGR-1.2%
Avg YoY Growth+9.6%
Median YoY Growth-8.3%
Current Streak2 quarters decline
2029 at Other Companies
Frequently Asked Questions
- What is Amgen's 2029?
- Amgen (AMGN) reported 2029 of $2.3B in Q1 2026.
- How has Amgen's 2029 changed year-over-year?
- Amgen's 2029 decreased by 17.9% year-over-year, from $2.8B to $2.3B.